GlassScriptPhysician profile
Jacques J Morcos
NPI 1205899937
$67,270.50
in general payments reported to CMS, 2019-2025
8 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $5,850 · 2021: $2,495 · 2022: $22K · 2023: $35K · 2024: $130 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $8,736 · Food and Beverage: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,875.00 |
| Travel and Lodging | $8,735.75 |
| Food and Beverage | $1,439.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $59,694.08 | 2021-2025 | Core, Sonopet Iq, Universal Neuro 3 |
| Leica Microsystems INC. | $6,779.14 | 2019-2021 | |
| Medtronic, INC. | $250.45 | 2023-2025 | Midas Rex |
| Alphatec Spine, INC | $172.42 | 2025 | Other - Miscellaneous |
| Depuy Synthes Sales INC. | $118.33 | 2021-2024 | |
| Acclarent, INC | $112.86 | 2019 | |
| Carl Zeiss Meditec, INC. | $94.67 | 2019 | |
| Nuvasive, INC. | $48.55 | 2023 | Simplify Cervical Artificial Disc, Reline, Xlif |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacques Morcos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.